Ariadne Wealth Management, LP Bristol Myers Squibb CO Transaction History
Ariadne Wealth Management, LP
- $192 Billion
- Q1 2025
A detailed history of Ariadne Wealth Management, LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ariadne Wealth Management, LP holds 5,014 shares of BMY stock, worth $250,549. This represents 0.12% of its overall portfolio holdings.
Number of Shares
5,014
Previous 7,272
31.05%
Holding current value
$250,549
Previous $404 Million
42.32%
% of portfolio
0.12%
Previous 0.18%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,811Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.56 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.93 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.4 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.74 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.32 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $106B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...